Cargando…

One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA(2)DS(2)-VASc Score

Background: CKD is a significant cause of morbidity, cardiovascular and all-cause mortality. CHA2DS2-VASc is a score used in patients with atrial fibrillation to predict thromboembolic risk; it also appears to be useful to predict mortality risk. The aim of the study was to evaluate CHA2DS2-VASc sco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abrantes, Ana Mafalda, Marques da Silva, Bernardo, Branco, Carolina, Costa, Cláudia, Peres, Nadiesda, Cardoso, Ana, Sant’Ana, Mariana, Fonseca, José Agapito, Outerelo, Cristina, Resina, Cristina, Lopes, José António, Gameiro, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917495/ https://www.ncbi.nlm.nih.gov/pubmed/36769658 http://dx.doi.org/10.3390/jcm12031011

Ejemplares similares

C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patients
por: Sant’Ana, Mariana, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Stroke in hemodialysis patients and its association with CHA(2)DS(2)-VASC and HAS-BLED scores: a retrospective study
por: Sab, Marc, et al.
Publicado: (2022)

Hypoalbuminaemia and One-Year Mortality in Haemodialysis Patients with Heart Failure: A Cohort Analysis
por: Cardoso, Ana, et al.
Publicado: (2021)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

Association of CHA(2)DS(2)-VASc Score With Remodeling of Left Atrial Appendage Assessed by Cardiac Computed Tomography
por: Cecconi, Alberto, et al.
Publicado: (2021)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

The impact of cigarette smoking in predicting stroke using CHADS(2) and CHA(2)DS(2)-VASc schemas
por: Zuo, Ming-Liang, et al.
Publicado: (2020)

Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0-2 With and Without Cancer
por: Leader, Avi, et al.
Publicado: (2023)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA(2)DS(2)-VASc Score in Anticoagulated Patients with Atrial Fibrillation
por: Carnevale, Roberto, et al.
Publicado: (2014)

The CHA(2)DS(2)‐VASc score as a predictor of high mortality in hospitalized heart failure patients
por: Yoshihisa, Akiomi, et al.
Publicado: (2016)

Association between modified CHA(2)DS(2)-VASc Score with Ankle-Brachial index < 0.9
por: Hsu, Po-Chao, et al.
Publicado: (2018)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Predicting stroke and death in patients with heart failure using CHA(2)DS(2)-VASc score in Asia
por: Son, Mi Kyoung, et al.
Publicado: (2019)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

The association between CHA(2)DS(2)-VASc score and erectile dysfunction: a cross-sectional study
por: Karabulut, Dilay, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke
por: Su, Chun-Hung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tu2sb907ilqkka0vbgalcgnr22